The UBIRIS. v2: A database of visible wavelength iris images captured on-the-move and at-a-distance H Proença, S Filipe, R Santos, J Oliveira, LA Alexandre IEEE Transactions on Pattern Analysis and Machine Intelligence 32 (8), 1529-1535, 2009 | 640 | 2009 |
Females with Fabry disease frequently have major organ involvement: lessons from the Fabry Registry WR Wilcox, JP Oliveira, RJ Hopkin, A Ortiz, M Banikazemi, ... Molecular genetics and metabolism 93 (2), 112-128, 2008 | 619 | 2008 |
COVID-19-related mortality in kidney transplant and dialysis patients: results of the ERACODA collaboration LB Hilbrands, R Duivenvoorden, P Vart, CFM Franssen, MH Hemmelder, ... Nephrology Dialysis Transplantation 35 (11), 1973-1983, 2020 | 448 | 2020 |
Recommendations for initiation and cessation of enzyme replacement therapy in patients with Fabry disease: the European Fabry Working Group consensus document M Biegstraaten, R Arngrímsson, F Barbey, L Boks, F Cecchi, PB Deegan, ... Orphanet journal of rare diseases 10, 1-10, 2015 | 378 | 2015 |
Nephropathy in males and females with Fabry disease: cross-sectional description of patients before treatment with enzyme replacement therapy A Ortiz, JP Oliveira, S Waldek, DG Warnock, B Cianciaruso, C Wanner, ... Nephrology Dialysis Transplantation 23 (5), 1600-1607, 2008 | 275 | 2008 |
Prognostic indicators of renal disease progression in adults with Fabry disease: natural history data from the Fabry Registry C Wanner, JP Oliveira, A Ortiz, M Mauer, DP Germain, GE Linthorst, ... Clinical Journal of the American Society of Nephrology 5 (12), 2220-2228, 2010 | 209 | 2010 |
European expert consensus statement on therapeutic goals in Fabry disease C Wanner, M Arad, R Baron, A Burlina, PM Elliott, U Feldt-Rasmussen, ... Molecular genetics and metabolism 124 (3), 189-203, 2018 | 200 | 2018 |
Screening, diagnosis, and management of patients with Fabry disease: conclusions from a “Kidney Disease: Improving Global Outcomes”(KDIGO) Controversies Conference R Schiffmann, DA Hughes, GE Linthorst, A Ortiz, E Svarstad, DG Warnock, ... Kidney international 91 (2), 284-293, 2017 | 200 | 2017 |
Renal outcomes of agalsidase beta treatment for Fabry disease: role of proteinuria and timing of treatment initiation DG Warnock, A Ortiz, M Mauer, GE Linthorst, JP Oliveira, AL Serra, ... Nephrology Dialysis Transplantation 27 (3), 1042-1049, 2012 | 197 | 2012 |
Scoring system for renal pathology in Fabry disease: report of the International Study Group of Fabry Nephropathy (ISGFN) AB Fogo, L Bostad, E Svarstad, WJ Cook, S Moll, F Barbey, L Geldenhuys, ... Nephrology Dialysis Transplantation 25 (7), 2168-2177, 2010 | 195 | 2010 |
Fibrosis: a key feature of Fabry disease with potential therapeutic implications F Weidemann, MD Sanchez-Niño, J Politei, JP Oliveira, C Wanner, ... Orphanet journal of rare diseases 8, 1-12, 2013 | 191 | 2013 |
The effect of enzyme replacement therapy on clinical outcomes in male patients with Fabry disease: a systematic literature review by a European panel of experts DP Germain, PM Elliott, B Falissard, VV Fomin, MJ Hilz, A Jovanovic, ... Molecular genetics and metabolism reports 19, 100454, 2019 | 184 | 2019 |
End-stage renal disease in patients with Fabry disease: natural history data from the Fabry Registry A Ortiz, B Cianciaruso, M Cizmarik, DP Germain, R Mignani, JP Oliveira, ... Nephrology Dialysis Transplantation 25 (3), 769-775, 2010 | 166 | 2010 |
Time to treatment benefit for adult patients with Fabry disease receiving agalsidase β: data from the Fabry Registry A Ortiz, A Abiose, DG Bichet, G Cabrera, J Charrow, DP Germain, ... Journal of Medical Genetics 53 (7), 495-502, 2016 | 165 | 2016 |
Eggplant (Solanum melongena) infusion has a modest and transitory effect on hypercholesterolemic subjects PR Guimarães, AMP Galvão, CM Batista, GS Azevedo, RD Oliveira, ... Brazilian Journal of Medical and Biological Research 33, 1027-1036, 2000 | 157 | 2000 |
Mutations of the GLA Gene in Young Patients With Stroke: The PORTYSTROKE Study—Screening Genetic Conditions in PORTuguese Young STROKE Patients MV Baptista, S Ferreira, T Pinho-e-Melo, M Carvalho, VT Cruz, ... Stroke 41 (3), 431-436, 2010 | 152 | 2010 |
How well does urinary lyso-Gb3 function as a biomarker in Fabry disease? C Auray-Blais, A Ntwari, JTR Clarke, DG Warnock, JP Oliveira, SP Young, ... Clinica chimica acta 411 (23-24), 1906-1914, 2010 | 145 | 2010 |
Prevention of ventilator-associated pneumonia J Oliveira, C Zagalo, P Cavaco-Silva Revista portuguesa de pneumologia 20 (3), 152-161, 2014 | 118 | 2014 |
Recommendations and guidelines for the diagnosis and treatment of Fabry nephropathy in adults A Ortiz, JP Oliveira, C Wanner, BM Brenner, S Waldek, DG Warnock Nature Clinical Practice Nephrology 4 (6), 327-336, 2008 | 108 | 2008 |
The alpha-galactosidase A p. Arg118Cys variant does not cause a Fabry disease phenotype: data from individual patients and family studies S Ferreira, A Ortiz, DP Germain, M Viana-Baptista, A Caldeira-Gomes, ... Molecular genetics and metabolism 114 (2), 248-258, 2015 | 99 | 2015 |